Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502240155

Apexbio Technology LLC EPZ031686,1mg CAS# 1808011-22-4
SDP

Supplier:  Apexbio Technology LLC B60821

Encompass_Preferred

EPZ031686 is the first SMYD3 inhibitor.Set and Mynd Domain containing 3 (SMYD3), a lysine methyltransferase (KMT) expressed at high levels in a number of different cancer histologies, is reported to be associated with a poor clinical prognosis.In vitro: EPZ031686 was the first SMYD3 inhibitor found to show double-digit nanomolar cellular activity. In addition, EPZ031686 displayed noncompetitive inhibition to both SAM and MEKK2 with a Ki = 1.2 and 1.1 nM, respectively. Moreover, EPZ031686 showed less than 30% inhibition against 16 histone methyltransferase targets at a 10 μM [1]. Other sizes are also available. Please inqury us for quote.

Catalog No. 50-224-0155


May include imposed supplier surcharges.
Only null left
Add to Cart
This item is not returnable. View return policy

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.